HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion
Hong Kong-listed Metis TechBio said on Monday it has entered into a collaboration agreement with Eli Lilly worth up to $1.1 billion to research and develop tissue-specific drug
October 19, 2026